Skip Navigation LinksHome > September 2008 - Volume 51 - Issue 3 > Hormone Therapy and Stroke
Clinical Obstetrics & Gynecology:
doi: 10.1097/GRF.0b013e318181df30
Evidence-Based Approach to Menopause

Hormone Therapy and Stroke

BIRGE, STANLEY J. MD

Collapse Box

Abstract

Available biochemical and clinical data are sufficiently compelling to recommend low dose or transdermal hormone therapy for the management of menopausal symptoms when possible. Women initiating low dose or transdermal hormone therapy are not at increased risk of cardiovascular disease, stroke, venous thrombotic disease, and breast cancer. Evidence suggests that these outcomes are favorably affected by low-dose hormone therapy and persist with continuation of therapy.

© 2008 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.